In accordance with the findings from the mRNA sequencing data, TIM-3, LAG-3 and CTLA-4 were expressed at higher levels in both CD4 and CD8 T cells from PD-1 resistant as compared with untreated EGFR TL tumours by flow cytometry analysis. The gene discussed is HAVCR2; the disease is neoplasm.